Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biocryst Pharma Inc
(NQ:
BCRX
)
8.100
+0.170 (+2.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biocryst Pharma Inc
< Previous
1
2
3
4
5
6
7
Next >
3 Stocks Insiders Are Buying
November 26, 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...
Via
Benzinga
BioCryst Shares Gain As Royalty Pharma Buys Additional Interests In BCX9930, Orladeyo
November 22, 2021
Royalty Pharma plc (NASDAQ: RPRX) and OMERS Capital Markets have announced transactions worth $350 million in new funding in BioCryst Pharmaceuticals...
Via
Benzinga
7 Top Growth Stocks to Buy as We Step Into November
November 12, 2021
Here are seven top growth stocks investors may want to consider when looking at options in this hyper-growth market right now.
Via
InvestorPlace
BioCryst Pharmaceuticals (BCRX) Q3 2021 Earnings Call Transcript
November 03, 2021
BCRX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Here's Why BioCryst Pharmaceuticals Stock Is Losing Ground Today
November 03, 2021
The biotech's third quarter was a good one, once you look past the top-line numbers.
Via
The Motley Fool
Analyzing BioCryst Pharmaceuticals's Unusual Options Activity
August 11, 2021
BioCryst Pharmaceuticals (NASDAQ:BCRX) shares experienced...
Via
Benzinga
Analyzing BioCryst Pharmaceuticals's Unusual Options Activity
July 30, 2021
Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) saw some...
Via
Benzinga
86 Biggest Movers From Yesterday
November 04, 2021
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 03, 2021
Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 03, 2021
Gainers Glaukos (NYSE:GKOS) stock increased by 25.55% to $56.58 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6 billion...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 20, 2021
Gainers Tenet Healthcare (NYSE:THC) stock r...
Via
Benzinga
2 Super-Charged Growth Stocks to Buy Now
October 13, 2021
These two small drugmakers are poised for a long-winded growth spurt.
Via
The Motley Fool
NICE Recommends BioCryst's Hereditary Angioedema Med
September 16, 2021
The U.K.'s National Institute for Health and Care Excellence (NICE) has recommended BioCryst Pharmaceuticals Inc's (NASDAQ: BCRX) Orladeyo (berotralstat)...
Via
Benzinga
US Government Exercises Option To Buy Additional Doses Of BioCryst's Flu Med
September 01, 2021
The U.S. Department of Health and Human Services (HHS) has exercised its option to purchase an additional 10,000 doses of BioCryst Pharmaceuticals Inc's (...
Via
Benzinga
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
August 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
COVID-19
Analyzing BioCryst Pharmaceuticals's Unusual Options Activity
August 16, 2021
BioCryst Pharmaceuticals (NASDAQ:BCRX) shares experienced unusual options activity on Monday. The stock price moved down to $15.44 following the option alert. Sentiment: BULLISH...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
BioCryst Stock Jumps After Pulling Out $200M Equity Raise
August 11, 2021
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has withdrawn its proposed public offering of $200 million of its stock and pre-funded warrants. The Company says...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 11, 2021
Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The...
Via
Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
August 11, 2021
Gainers CohBar, Inc. (NASDAQ: CWBR) shares rose 78.3% to $2.30 in pre-market trading after the company reported results from the Phase 1a/1b study of CB4211 under development for...
Via
Benzinga
28 Stocks Moving in Tuesday's Pre-Market Session
August 10, 2021
Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 38.6% to $66.88 in pre-market trading after the company reported better-than-expected Q2 earnings and also...
Via
Benzinga
85 Biggest Movers From Yesterday
August 11, 2021
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...
Via
Benzinga
54 Stocks Moving In Tuesday's Mid-Day Session
August 10, 2021
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy...
Via
Benzinga
BioCryst Pharmaceuticals (BCRX) Q2 2021 Earnings Call Transcript
August 06, 2021
BCRX earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why BioCryst Pharmaceuticals Rose 8% on Thursday
August 05, 2021
The company's first commercial drug launch keeps exceeding expectations.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Product Safety
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
BioCryst Pharma Stock Heads Higher Thursday: Here's Why
August 05, 2021
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) shares were trading higher Thursday after the company reported second-quarter financial results. The company reported revenue of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 05, 2021
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares rose 42.78% to $5.84 during Thursday's pre-market session. The company's market cap stands at $141.7 million....
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2021
August 03, 2021
Upgrades For SolarEdge Technologies Inc (NASDAQ:
Via
Benzinga
Analyzing BioCryst Pharmaceuticals's Unusual Options Activity
July 29, 2021
BioCryst Pharmaceuticals (NASDAQ:BCRX) shares experienced unusual options activity on Thursday. The stock price moved up to $16.93 following the option alert. Sentiment: BULLISH...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.